Glyn Edwards News
Most Popular Glyn Edwards Story
Antisoma starts licensing spree with cancer deal
Bankrolled by a $125 million licensing deal with Novartis, the UK's Antisoma has turned around and used part of its... Read more...
Latest Headlines
- April 14, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
